Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Perna

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|October 11, 2007
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy?Dino Vaira, Federico Perna
Journal of Clinical Pathology|June 3, 2010
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibilityFederico Perna, Dino Vaira
Alimentary Pharmacology & Therapeutics|May 8, 2026
Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE StudyFederico Perna, Angelo Armandi
Diseases of the Colon and Rectum|October 18, 2005
Descending perineum syndrome: are abdominal hysterectomy and bowel habits linked?Filippo Pucciani, Daniele Boni, Federico Perna, et al.
Annals of Diagnostic Pathology|February 8, 2018
Primary jejunal interdigitating dendritic cell sarcomaFrancesco Guerra, Alessandra Vegni, Federico Perna, et al.
Digestive Diseases (Basel, Switzerland)|September 11, 2007
How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapyDino Vaira, Chiara Ricci, Alberto Lanzini, et al.
International Journal of Antimicrobial Agents|December 23, 2008
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantisBeatrice Vitali, Federico Perna, Karen Lammers, et al.
Diseases of the Colon and Rectum|April 13, 2007
Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic modelFabio Cianchi, Luca Messerini, Camilla Eva Comin, et al.
The American Journal of Gastroenterology|October 24, 2003
Susceptibility of Helicobacter pylori to metronidazoleFederico Perna, Luigi Gatta, Natale Figura, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|December 14, 2020
Average treatment effect of robotic versus laparoscopic rectal surgery for rectal cancerLeonardo Solaini, Federico Perna, Davide Cavaliere, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nature Clinical Practice. Gastroenterology & Hepatology|October 11, 2007
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy?Dino Vaira, Federico Perna
Journal of Clinical Pathology|June 3, 2010
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibilityFederico Perna, Dino Vaira
Alimentary Pharmacology & Therapeutics|May 8, 2026
Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE StudyFederico Perna, Angelo Armandi
Diseases of the Colon and Rectum|October 18, 2005
Descending perineum syndrome: are abdominal hysterectomy and bowel habits linked?Filippo Pucciani, Daniele Boni, Federico Perna, et al.
Annals of Diagnostic Pathology|February 8, 2018
Primary jejunal interdigitating dendritic cell sarcomaFrancesco Guerra, Alessandra Vegni, Federico Perna, et al.
Digestive Diseases (Basel, Switzerland)|September 11, 2007
How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapyDino Vaira, Chiara Ricci, Alberto Lanzini, et al.
International Journal of Antimicrobial Agents|December 23, 2008
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantisBeatrice Vitali, Federico Perna, Karen Lammers, et al.
Diseases of the Colon and Rectum|April 13, 2007
Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic modelFabio Cianchi, Luca Messerini, Camilla Eva Comin, et al.
The American Journal of Gastroenterology|October 24, 2003
Susceptibility of Helicobacter pylori to metronidazoleFederico Perna, Luigi Gatta, Natale Figura, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|December 14, 2020
Average treatment effect of robotic versus laparoscopic rectal surgery for rectal cancerLeonardo Solaini, Federico Perna, Davide Cavaliere, et al.
Pageof 4